Currently out of the existing stock ratings of Colleen Kusy, 61 are a BUY (85.92%), 10 are a HOLD (14.08%).

Colleen Kusy

Work Performance Price Targets & Ratings Chart

Analyst Colleen Kusy, currently employed at BAIRD, carries an average stock price target met ratio of 52% that have a potential upside of 39.57% achieved within 153 days.

Colleen Kusy’s has documented 137 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 27-Jul-2026.

Wall Street Analyst Colleen Kusy

Analyst best performing recommendations are on NUVL (NUVALENT).
The best stock recommendation documented was for NUVL (NUVALENT) at 9/10/2024. The price target of $105 was fulfilled within 6 days with a profit of $17.51 (20.01%) receiving and performance score of 33.36.

Average potential price target upside

OCS Oculis Holding AG Ordinary shares AGEN Agenus APLS Apellis Pharmaceuticals ARGX argenx NV ADR CHRS Coherus BioSciences COGT Cogent Biosciences ELVN Enliven Therapeutics IOVA Iovance Biotherapeutics ISEE IVERIC bio NUVL Nuvalent OCUL Ocular Therapeutix SURF Surface Oncology SYRE Spyre Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Jun-2023

$39

$28.86 (284.62%)

$26

Buy Since 19-Mar-2024

$38

$26 (216.67%)

$41

3 months 19 days ago
(02-Jun-2026)

0/4 (0%)

$25.71 (209.19%)

Buy Since 27-Aug-2025

$46

$34 (283.33%)

$40

4 months 9 days ago
(12-May-2026)

0/4 (0%)

$15.59 (51.27%)

Buy Since 05-Oct-2023

$50

$38 (316.67%)

$40

6 months 16 days ago
(05-Mar-2026)

0/7 (0%)

$22.26 (80.25%)

Buy Since 14-Jun-2023

$29

$17 (141.67%)

$30

10 months 8 days ago
(13-Nov-2025)

6/6 (100%)

$9.71 (50.34%)

474

Show more analysts

Please expand the browser size to see the chart

Which stock is Colleen Kusy most bullish on?

Potential upside of $27.86 has been obtained for OCS (OCULIS HOLDING AG ORDINARY SHARES)

Which stock is Colleen Kusy most reserved on?

Potential downside of -$58.32 has been obtained for ARGX (ARGENX NV ADR)

What Year was the first public recommendation made by Colleen Kusy?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?